Harvard Perspectives on Prostate Disease

Advances and breakthroughs in prostate disease

Reviewed by Per-Anders Abrahamsson, M.D., Ph.D.

Advances in the understanding and treatment of prostate disease are constantly being reported at scientific meetings and in peer-reviewed publications. What follows are some of the most interesting recent findings, placed in context by Per-Anders Abrahamsson, a member of Perspectives' editorial and advisory board and Secretary General of the European Association of Urology, the leading professional organization overseas.

Testosterone seen unrelated to prostate cancer risk

Researchers have long believed that male sex hormones, including testosterone, influence the risk of prostate cancer. However, a collaborative analysis of 18 prospective studies, published in February, determined that they are not associated with prostate cancer risk.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »